Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada · Delayed Price · Currency is CAD

4.930

-0.110 (-2.18%)

Oct 30, 2026, 4:00 PM EDT

Medexus Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	103.3	99.33	108.33	113.05	108.1	76.7
Revenue Growth	-2.23%	-8.31%	-4.18%	4.59%	40.93%	-3.72%
Gross Profit	65.97	63.86	63.51	65.07	65.77	43.67
Operating Income	7.1	5.84	11.92	12.79	8.49	-12.38
Net Income	-2.37	-2.39	2.25	-0.21	1.22	-2.88
Earnings Per Share	-0.07	-0.07	0.08	-0.01	0.06	-0.15
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
United States	79.18	74.74	68.61	77.18	78.94	52.01
Canada	24.13	24.59	39.72	35.87	29.16	24.7
Total	103.3	99.33	108.33	113.05	108.1	76.7

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	5.34	6.52	23.97	5.26	13.07	10.02
Total Debt	26.25	22.26	37.18	49.9	70.08	54.86
Net Cash (Debt)	-20.91	-15.74	-13.21	-44.64	-57.01	-44.84
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.65	-0.49	-0.50	-2.00	-2.78	-2.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	14.23	18.87	24.03	18.71	-1.44	-1.18
Capital Expenditures	-0.05	-0.15	-0.18	-0.05	-0.06	-0.1
Free Cash Flow	14.18	18.72	23.85	18.66	-1.51	-1.28
Free Cash Flow Growth	-27.24%	-21.51%	27.79%	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	63.86%	64.29%	58.62%	57.56%	60.84%	56.94%
Operating Margin	6.87%	5.87%	11.00%	11.31%	7.85%	-16.13%
Pretax Margin	-2.31%	-2.29%	1.33%	0.09%	-4.66%	-4.98%
Profit Margin	-2.29%	-2.41%	2.07%	-0.19%	1.13%	-3.75%
FCF Margin	13.72%	18.85%	22.02%	16.51%	-1.39%	-1.67%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	-	-	24.17	-	19.55	-
Forward PE	13.07	7.48	19.63	5.21	43.87	43.87
P/FCF Ratio	7.87	3.85	2.28	1.56	-	-
PS Ratio	1.08	0.73	0.50	0.26	0.22	0.65